Z-1338-2019 Class II Terminated

Recalled by Integra Limited — Plainsboro, NJ

FDA device recall Z-1338-2019 was initiated by Integra Limited on Mar 31, 2019 and is designated Class II. Reason for recall: Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months The recall status is terminated (terminated May 7, 2020). Affected quantity: 274 units.

Recall details

Product Type
Devices
Report Date
May 22, 2019
Initiation Date
Mar 31, 2019
Termination Date
May 7, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
274 units

Product description

Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.

Reason for recall

Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months

Distribution pattern

Worldwide Distribution - US Nationwide Foreign; Peru, Ecuador, Columbia, Brazil

Code information

Lot Code: 2991332

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1338-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1338-2019. Report a data issue: hello@regdatalab.com.